Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Small Cell Lung Carcinoma
and you are
between 18 and 70
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to determine whether green tea extract is safe for extensive-stage small lung cancer who achieved objective tumor response after first-line therapy.

Provided treatments

  • : epigallocatechin gallate
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01317953. The sponsor of the trial is Shandong Cancer Hospital and Institute and it is looking for 0 volunteers for the current phase.
Official trial title:
Phase ⅠStudy of Oral Green Tea Extract as Maintenance Therapy for Extensive-stage Small Cell Lung Cancer